The assessment of antimalarial drug efficacy.

The assessment of antimalarial drug efficacy.

Antimalarial drug efficacy in uncomplicated malaria should be assessed parasitologically in large, community-based trials, enrolling the age groups most affected by clinical disease. For rapidly eliminated drugs, a 28-day follow-up is needed, but, for slowly eliminated drugs, up to nine weeks could...

Szczegółowa specyfikacja

Opis bibliograficzny
1. autor:	White, N
Format:	Journal article
Język:	English
Wydane:	2002

Podobne zapisy

The assessment of antimalarial drug efficacy in vivo
od: White, NJ
Wydane: (2022)

Monitoring antimalarial drug efficacy - Reply
od: Mayxay, M, i wsp.
Wydane: (2004)

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.
od: White, N
Wydane: (1997)

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
od: Price, R, i wsp.
Wydane: (2007)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
od: Price, R, i wsp.
Wydane: (2007)

Antimalarial drug resistance
od: White, N
Wydane: (2004)

Cardiotoxicity of antimalarial drugs.
od: White, N
Wydane: (2007)

Antimalarial drug resistance.
od: White, N
Wydane: (2004)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
od: Olliaro Piero, i wsp.
Wydane: (2007-09-01)

Clinical pharmacokinetics of antimalarial drugs.
od: White, N
Wydane: (1985)

Monitoring antimalarial drug efficacy [1] (multiple letters)
od: Ringwald, P, i wsp.
Wydane: (2004)

The threat of antimalarial drug resistance
od: Hanboonkunupakarn, B, i wsp.
Wydane: (2016)

Antimalarial drug resistance: the pace quickens.
od: White, N
Wydane: (1992)

Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
od: Barnes, K, i wsp.
Wydane: (2005)

Antimalarial drug toxicity: a review.
od: Taylor, W, i wsp.
Wydane: (2004)

Mode of action and features of antimalarial drugs
od: Nosten, F, i wsp.
Wydane: (1999)

Mode of action and features of antimalarial drugs.
od: Nosten, F, i wsp.
Wydane: (1999)

Antimalarial efficacy and toxicological assessment of medicinal plant ingredients of Prabchompoothaweep remedy as a candidate for antimalarial drug development
od: Prapaporn Chaniad, i wsp.
Wydane: (2023-01-01)

Delaying antimalarial drug resistance with combination chemotherapy.
od: White, N
Wydane: (1999)

Preventing antimalarial drug resistance through combinations.
od: White, N
Wydane: (1998)

Antimalarial dosing regimens and drug resistance.
od: Barnes, K, i wsp.
Wydane: (2008)

In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand.
od: Chotivanich, K, i wsp.
Wydane: (2004)

Why is it that antimalarial drug treatments do not always work?
od: White, N
Wydane: (1998)

The difference between effectiveness and efficacy of antimalarial drugs in Kenya.
od: Amin, A, i wsp.
Wydane: (2004)

Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.
od: Stepniewska, K, i wsp.
Wydane: (2008)

A colorimetric field method to assess the authenticity of drugs sold as the antimalarial artesunate.
od: Green, MD, i wsp.
Wydane: (2000)

How antimalarial drug resistance affects post-treatment prophylaxis.
od: White, N
Wydane: (2008)

Antimalarial mass drug administration: ethical considerations
od: Cheah, PY, i wsp.
Wydane: (2016)

Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria.
od: Pukrittayakamee, S, i wsp.
Wydane: (2004)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
od: Shibeshi MA, i wsp.
Wydane: (2020-11-01)

Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs
od: Earnest Oghenesuvwe Erhirhie, i wsp.
Wydane: (2021-01-01)

Hypoglycaemia and antimalarial drugs: quinidine and release of insulin.
od: Phillips, R, i wsp.
Wydane: (1986)

Does antimalarial mass drug administration increase or decrease the risk of resistance?
od: White, N
Wydane: (2016)

Split dosing of artemisinins does not improve antimalarial therapeutic efficacy
od: White, N, i wsp.
Wydane: (2017)

A systematic overview of published antimalarial drug trials.
od: Myint, H, i wsp.
Wydane: (2004)

Effectiveness of antimalarial drugs.
od: Baird, J
Wydane: (2005)

Toxicity of antimalarial drugs.
od: Peto, T
Wydane: (1989)

Efficacy of existing antimalarial drugs for uncomplicated malaria in Timika, Papua, Indonesia
od: Siswantaro, H, i wsp.
Wydane: (2006)

How do patients use antimalarial drugs? A review of the evidence.
od: Yeung, S, i wsp.
Wydane: (2005)

Therapeutic responses to different antimalarial drugs in vivax malaria.
od: Pukrittayakamee, S, i wsp.
Wydane: (2000)